ESTIMATION OF INFORMATIVE VALUE OF ANTHROPOMETRIC PARAMETERS AND PREGNANCY COMPLICATIONS TO PREDICT PREECLAMPSIA

Main Article Content

Индира Венеровна Сахаутдинова
Ирина Вениаминовна Герасимова

Abstract

The aim of the research – the aim of the study was to evaluate the effectiveness of the analysis of the anthropometric parameters of patients, overall weight gain and edematous syndrome as predictors of preeclampsia.

Materials and methods. We conducted a randomized retrospective study. Group I included 34 patients with preeclampsia, group II included 66 patients, pregnancy, childbirth and the postpartum period were not complicated by hypertensive disorders. We analyzed the anthropometric parameters of patients at 12-14 weeks of gestation, as well as edematous syndrome at 30 weeks and overall weight gain in this period.

Results. In the group of patients with late preeclampsia, BMI is close to the upper limit of normal. In the group of patients with early preeclampsia, a combination of edematous syndrome with low weight gain was noted.

Conclusion. We recommend that at the stage of preconception preparation it is required to bring the BMI parameters to the average acceptable ones. The edematous syndrome should be considered as a predictor of preeclampsia. The combination of edematous syndrome and low weight gain should be regarded as a predictor of preeclampsia.

Downloads

Download data is not yet available.

Article Details

Section

ORIGINAL ARTICLES

Author Biographies

Индира Венеровна Сахаутдинова, Bashkir State Medical University, Ufa

doctor of medical sciences, professor, head of the department of obstetrics and gynecology n 1

Ирина Вениаминовна Герасимова, Clinical Hospital «Mother and Child», Ufa

obstetrician-gynecologist, head of the obstetric department of pregnancy pathology

References

WHO 2019. https://www.who.int/news-room/fact-sheets/detail/maternal-mortality

Ma'ayeh M, Costantine MM. Prevention of preeclampsia. Semin Fetal Neonatal Med. 2020; 25(5): 101123. doi: 10.1016/j.siny.2020.10112

Espinoza J, Vidaeff A, Pettker CM, Simhan H. Gestational hypertension and preeclampsia. Obstetrics & Gynecology. 2019; 133(1): 1-3. doi: 10.1097/aog.0000000000003018

Smith AN, Wang X, Thomas DG, Tatum RE, Booz GW, Cunningham MW. The Role of Mitochondrial Dysfunction in Preeclampsia: Causative Factor or Collateral Damage? Am J Hypertens. 2021; 34(5): 442-452. doi: 10.1093/ajh/hpab003

Miller D, Motomura K, Galaz J, Gershater M, Lee ED, Romero R, Gomez-Lopez N. Cellular immune responses in the pathophysiology of preeclampsia. J Leukoc Biol. 2022; 111(1): 237-260. doi: 10.1002/JLB.5RU1120-787RR

Rana S, Lemoine E, Granger JP, Karumanchi SA. Preeclampsia: Pathophysiology, Challenges, and Perspectives. Circ Res. 2019; 124(7): 1094-1112. doi: 10.1161/CIRCRESAHA.118.313276

ACOG Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia. Obstet Gynecol. 2019; 133(1): 1. doi: 10.1097/AOG.0000000000003018

Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. Int J Gynaecol Obstet. 2019; 145 Suppl 1(Suppl 1): 1-33

Tomimatsu T, Mimura K, Matsuzaki S, Endo M, Kumasawa K, Kimura T. Preeclampsia: Maternal Systemic Vascular Disorder Caused by Generalized Endothelial Dysfunction Due to Placental Antiangiogenic Factors. Int J Mol Sci. 2019; 20(17): 4246. doi: 10.3390/ijms20174246

Phipps EA, Thadhani R, Benzing T, Karumanchi SA. Pre-eclampsia: pathogenesis, novel diagnostics and therapies. Nat. Rev. Nephrol. 2019; 15: 275-289. doi: 10.1038/s41581-019-0119-6

Cheng SB, Nakashima A, Huber WJ, Davis S, Banerjee S, Huang Z, et al. Pyroptosis is a critical inflammatory pathway in the placenta from early onset preeclampsia and in human trophoblasts exposed to hypoxia and endoplasmic reticulum stressors. Cell Death Dis. 2019; 10(12): 927. doi: 10.1038/s41419-019-2162-4

Aneman I, Pienaar D, Suvakov S, Simic TP, Garovic VD, McClements L. Mechanisms of Key Innate Immune Cells in Early- and Late-Onset Preeclampsia. Front Immunol. 2020; 11: 1864. doi: 10.3389/fimmu.2020.01864

Yang Y, Le Ray I, Zhu J, Zhang J, Hua J, Reilly M. Preeclampsia Prevalence, Risk Factors, and Pregnancy Outcomes in Sweden and China. JAMA Netw Open. 2021; 4(5): e218401. doi: 10.1001/jamanetworkopen.2021.8401

Sormunen-Harju H, Koivusalo S, Gissler M, Metsälä J. The risk of complications in second pregnancy by maternal BMI: The role of first-pregnancy complications, pregestational diabetes and chronic hypertension. Acta Obstet Gynecol Scand. 2021; 100(3): 489-496. doi: 10.1111/aogs.14028

Carbillon L, Boujenah J. Edema associated with low plasma protein level and any gestational hypertension as warning signs of HELLP syndrome. J Matern Fetal Neonatal Med. 2021: 1-4. doi: 10.1080/14767058.2021.1949444

Most read articles by the same author(s)